Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease

Inflammatory Bowel Diseases

Volumn 13, Issue 9, 2007, Pages 1121-1128

  Thayu, Meena ^a   Shults, Justine ^a   Burnham, Jon M ^a   Zemel, Babette S ^a   Baldassano, Robert N ^a   Leonard, Mary B ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Body composition; Cachexia; Crohn's disease; Fat mass; Growth failure; Inflammatory bowel disease; Lean mass

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DISEASE ACTIVITY; FAT BODY; FEMALE; HUMAN; LABORATORY TEST; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGE FACTORS; ANTHROPOMETRY; BODY COMPOSITION; BODY MASS INDEX; CACHEXIA; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; FEMALE; HUMANS; MALE; REGRESSION ANALYSIS; SEX FACTORS;

EID: 34548613762     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20149     Document Type: Article

References (50)

1. Ellis KJ. Human body composition: in vivo methods. Physiol Rev. 2000;80:649-680.
2. Bechard L, Puig M. Body composition and growth. In: Walker W, Watkins J, Duggan C. eds. Nutrition in pediatrics. London: BC Decker; 2003:32-51.
3. Roubenoff R, Kehayias JJ. The meaning and measurement of lean body mass. Nutr Rev. 1991;49:163-175.
4. Schonau E, Werhahn E, Schiedermaier U, et al. Influence of muscle strength on bone strength during childhood and adolescence. Horm Res. 1996;45(Suppl 1):63-66.
5. Burnham JM, Shults J, Semeao E, et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res. 2004;19:1961-1968.
6. Boot AM, Bouquet J, Krenning EP, et al. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998;42:188-194.
7. Capristo E, Addolorato G, Mingrone G, et al. Effect of disease localization on the anthropometric and metabolic features of Crohn's disease. Am J Gastroenterol. 1998;93:2411-2419.
8. Capristo E, Mingrone G, Addolorato G, et al. Metabolic features of inflammatory bowel disease in a remission phase of the disease activity. J Intern Med. 1998;243:339-347.
9. Mingrone G, Benedetti G, Capristo E, et al. Twenty-four-hour energy balance in Crohn disease patients: metabolic implications of steroid treatment. Am J Clin Nutr. 1998;67:118-123.
10. Haderslev KV, Jeppesen PB, Sorensen HA, et al. Body composition measured by dual-energy X-ray absorptiometry in patients who have undergone small-intestinal resection. Am J Clin Nutr. 2003;78:78-83.
11. Azcue M, Rashid M, Griffiths A, et al. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut. 1997;41:203-208.
12. Jahnsen J, Falch JA, Mowinckel P, et al. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2003;98:1556-1562.
13. Geerling BJ, Lichtenbelt WD, Stockbrugger RW, et al. Gender specific-alterations of body composition in patients with inflammatory bowel disease compared with controls. Eur J Clin Nutr. 1999;53:479-485.
14. Schneeweiss B, Lochs H, Zauner C, et al. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr. 1999;129:844-848.
15. Burnham JM, Shults J, Semeao E, et al. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr. 2005;82:413-420.
16. Roubenoff R, Roubenoff RA, Ward LM, et al. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol. 1992;19:1505-1510.
17. Rail LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxf). 2004;43:1219-1223.
18. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
19. Morris NN, Udry JR. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc. 1980:271-280.
20. Tanner JM. Growth at adolescence. London: Blackwell Scientific; 1962.
21. Foster BJ, Shults J, Zemel BS, et al. Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids. Am J Clin Nutr. 2004;80:1334-1341.
22. Ellis KJ, Shypailo RJ, Abrams SA, et al. The reference child and adolescent models of body composition. A contemporary comparison. Ann N Y Acad Sci. 2000;904:374-382.
23. Ellis KJ. Body composition of a young, multiethnic, male population. Am J Clin Nutr. 1997;66:1323-1331.
24. Ellis KJ, Abrams SA, Wong WW. Body composition reference data for a young multiethnic female population. Appl Radiat Isot. 1998;49:587-588.
25. Goulding A, Taylor RW, Gold E, et al. Regional body fat distribution in relation to pubertal stage: a dual-energy X-ray absorptiometry study of New Zealand girls and young women. Am J Clin Nutr. 1996;64:546-551.
26. Ogle GD, Allen JR, Humphries IR, et al. Body-composition assessment by dual-energy x-ray absorptiometry in subjects aged 4-26 y. Am J Clin Nutr. 1995;61:746-753.
27. Lloyd T, Chinchilli VM, Eggli DF, et al. Body composition development of adolescent white females: the Penn State Young Women's Health Study. Arch Pediatr Adolesc Med. 1998;152:998-1002.
28. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109:45-60.
29. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr. 1990;44:45-60.
30. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:255-281.
31. Schutte JE, Townsend EJ, Hugg J, et al. Density of lean body mass is greater in blacks than in whites. J Appl Physiol Resp Environ Exerc Physiol. 1984;56:1647-1649.
32. Sentongo TA, Semeao EJ, Piccoli DA, et al. Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr. 2000;31:33-40.
33. Ma K, Mallidis C, Bhasin S, et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab. 2003;285:E363-371.
34. Dimitriadis G, Leighton B, Parry-Billings M, et al. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J. 1997;321(Pt 3):707-712.
35. Clowes GH Jr, George BC, Villee CA Jr, et al. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. 1983. Nutrition. 1995;11:775; discussion 774, 776-777.
36. Guttridge DC, Mayo MW, Madrid LV, et al. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000;289:2363-2366.
37. Fan J, Char D, Bagby GJ, et al. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol. 1995;269:R1204-1212.
38. Tirapegui J. Effect of insulin-like growth factor-1 (IGF-1) on muscle and bone growth in experimental models. Int J Food Sci Nutr. 1999;50:231-236.
39. Kirschner BS, Sutton MM. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology. 1986;91:830-836.
40. Corkins MR, Gohil AD, Fitzgerald JF. The insulin-like growth factor axis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2003;36:228-234.
41. Thomas AG, Holly JM, Taylor F, et al. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut. 1993;34:944-947.
42. Plevy SE, Landers CJ, Prehn J, et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol. 1997;159:6276-6282.
43. Sylvester FA, Davis PM, Wyzga N, et al. Are activated T cells regulators of bone metabolism in children with Crohn disease? J Pediatr. 2006;148:461-466.
44. Markowitz J, Grancher K, Rosa J, et al. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1993;16:373-380.
45. Griffiths A, Nguyen P, Smith C, et al. Growth and clinical course of children with Crohn's disease. Gut. 1993;34:939-943.
46. Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006;84:475-482.
47. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006;83:735-743.
48. Parfitt AM. The two faces of growth: benefits and risks to bone integrity. Osteoporos Int. 1994;4:382-398.
49. Semeao EJ, Stallings VA, Peck SN, et al. Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology. 1997;112:1710-1713.
50. Sylvester FA. Cracking the risk of fractures in Crohn disease. J Pediatr Gastroenterol Nutr. 2004;38:113-114.